Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.63 USD | +6.28% | +10.50% | +71.91% |
09/05 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
07/05 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+71.91% | 561.55Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-0.38% | 2.23TCr | |
-12.15% | 2.21TCr | |
-7.66% | 1.87TCr | |
-36.52% | 1.76TCr | |
-10.09% | 1.69TCr | |
+3.33% | 1.38TCr | |
+36.58% | 1.25TCr |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Piper Sandler Downgrades ImmunityBio to Neutral From Overweight, Cuts Price Target to $4 From $10